1 |
Marin-Valencia, I., Yang, C., Mashimo, T., Cho, S., Baek, H., Yang, X. L., Rajagopalan, K. N., Maddie, M., Vemireddy, V., Zhao, Z., Cai, L., Good, L., Tu, B. P., Hatanpaa, K. J., Mickey, B. E., Mates, J. M., Pascual, J. M., Maher, E. A., Malloy, C. R., Deberardinis, R. J. and Bachoo, R. M. (2012) Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab. 15, 827-837.
DOI
|
2 |
Marquez, J., Alonso, F. J., Mates, J. M., Segura, J. A., Martin-Rufian, M. and Campos-Sandoval, J. A. (2017) Glutamine addiction in gliomas. Neurochem. Res. 42, 1735-1746.
DOI
|
3 |
Masson, J., Darmon, M., Conjard, A., Chuhma, N., Ropert, N., Thoby- Brisson, M., Foutz, A. S., Parrot, S., Miller, G. M., Jorisch, R., Polan, J., Hamon, M., Hen, R. and Rayport, S. (2006) Mice lacking brain/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth. J. Neurosci. 26, 4660-4671.
DOI
|
4 |
Mates, J. M., Segura, J. A., Martin-Rufian, M., Campos-Sandoval, J. A., Alonso, F. J. and Marquez, J. (2013) Glutaminase isoenzymes as key regulators in metabolic and oxidative stress against cancer. Curr. Mol. Med. 13, 514-534.
DOI
|
5 |
Metallo, C. M., Gameiro, P. A., Bell, E. L., Mattaini, K. R., Yang, J., Hiller, K., Jewell, C. M., Johnson, Z. R., Irvine, D. J., Guarente, L., Kelleher, J. K., Vander Heiden, M. G., Iliopoulos, O. and Stephanopoulos, G. (2011) Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia. Nature 481, 380-384.
|
6 |
Mohamed, A., Deng, X., Khuri, F. R. and Owonikoko, T. K. (2014) Altered glutamine metabolism and therapeutic opportunities for lung cancer. Clin. Lung Cancer 15, 7-15.
|
7 |
DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G. and Thompson, C. B. (2008) The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 7, 11-20.
DOI
|
8 |
Davidson, S. M., Papagiannakopoulos, T., Olenchock, B. A., Heyman, J. E., Keibler, M. A., Luengo, A., Bauer, M. R., Jha, A. K., O'Brien, J. P., Pierce, K. A., Gui, D. Y., Sullivan, L. B., Wasylenko, T. M., Subbaraj, L., Chin, C. R., Stephanopolous, G., Mott, B. T., Jacks, T., Clish, C. B. and Vander Heiden, M. G. (2016) Environment impacts the metabolic dependencies of ras-driven non-small cell lung cancer. Cell Metab. 23, 517-528.
DOI
|
9 |
Daye, D. and Wellen, K. E. (2012) Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis. Semin. Cell Dev. Biol. 23, 362-369.
DOI
|
10 |
DeBerardinis, R. J. and Cheng, T. (2010) Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29, 313-324.
DOI
|
11 |
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S. and Thompson, C. B. (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc. Natl. Acad. Sci. U.S.A. 104, 19345-19350.
DOI
|
12 |
Dewaele, M., Maes, H. and Agostinis, P. (2010) ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy. Autophagy 6, 838-854.
DOI
|
13 |
Duran, R. V., Oppliger, W., Robitaille, A. M., Heiserich, L., Skendaj, R., Gottlieb, E. and Hall, M. N. (2012) Glutaminolysis activates RagmTORC1 signaling. Mol. Cell 47, 349-358.
|
14 |
Eagle, H. (1955) Nutrition needs of mammalian cells in tissue culture. Science 122, 501-514.
DOI
|
15 |
Sanchez, E. L., Carroll, P. A., Thalhofer, A. B. and Lagunoff, M. (2015) Latent KSHV Infected Endothelial Cells Are Glutamine Addicted and Require Glutaminolysis for Survival. PLoS Pathog. 11, e1005052.
DOI
|
16 |
Nazio, F., Strappazzon, F., Antonioli, M., Bielli, P., Cianfanelli, V., Bordi, M., Gretzmeier, C., Dengjel, J., Piacentini, M., Fimia, G. M. and Cecconi, F. (2013) mTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6. Nat. Cell Biol. 15, 406-416.
DOI
|
17 |
Qing, G., Li, B., Vu, A., Skuli, N., Walton, Z. E., Liu, X., Mayes, P. A., Wise, D. R., Thompson, C. B., Maris, J. M., Hogarty, M. D. and Simon, M. C. (2012) ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell 22, 631-644.
DOI
|
18 |
Sancak, Y., Peterson, T. R., Shaul, Y. D., Lindquist, R. A., Thoreen, C. C., Bar-Peled, L. and Sabatini, D. M. (2008) The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501.
DOI
|
19 |
Saxton, R. A., Knockenhauer, K. E., Wolfson, R. L., Chantranupong, L., Pacold, M. E., Wang, T., Schwartz, T. U. and Sabatini, D. M. (2016) Structural basis for leucine sensing by the Sestrin2-mTORC1 pathway. Science 351, 53-58.
DOI
|
20 |
Eng, C. H., Yu, K., Lucas, J., White, E. and Abraham, R. T. (2010) Ammonia derived from glutaminolysis is a diffusible regulator of autophagy. Sci. Signal. 3, ra31.
|
21 |
Son, J., Lyssiotis, C. A., Ying, H., Wang, X., Hua, S., Ligorio, M., Perera, R. M., Ferrone, C. R., Mullarky, E., Shyh-Chang, N., Kang, Y., Fleming, J. B., Bardeesy, N., Asara, J. M., Haigis, M. C., DePinho, R. A., Cantley, L. C. and Kimmelman, A. C. (2013) Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway. Nature 496, 101-105.
|
22 |
Suzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., Sugano, S., Sato, E., Nagao, T., Yokote, K., Tatsuno, I. and Prives, C. (2010) Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 107, 7461-7466.
DOI
|
23 |
Gaglio, D., Soldati, C., Vanoni, M., Alberghina, L. and Chiaradonna, F. (2009) Glutamine deprivation induces abortive s-phase rescued by deoxyribonucleotides in k-ras transformed fibroblasts. PLoS ONE 4, e4715.
DOI
|
24 |
Szeliga, M., Bogacinska-Karas, M., Kuzmicz, K., Rola, R. and Albrecht, J. (2016) Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status. Mol. Carcinog. 55, 1309-1316.
DOI
|
25 |
Tanaka, K., Sasayama, T., Irino, Y., Takata, K., Nagashima, H., Satoh, N., Kyotani, K., Mizowaki, T., Imahori, T., Ejima, Y., Masui, K., Gini, B., Yang, H., Hosoda, K., Sasaki, R., Mischel, P. S. and Kohmura, E. (2015) Compensatory glutamine metabolism promotes glioblastoma resistance to mTOR inhibitor treatment. J. Clin. Invest. 125, 1591-1602.
|
26 |
Thai, M., Thaker, S. K., Feng, J., Du, Y., Hu, H., Ting Wu, T., Graeber, T. G., Braas, D. and Christofk, H. R. (2015) MYC-induced reprogramming of glutamine catabolism supports optimal virus replication. Nat. Commun. 6, 8873.
DOI
|
27 |
Fernandez-Medarde, A. and Santos, E. (2011) Ras in cancer and developmental diseases. Genes Cancer 2, 344-358.
DOI
|
28 |
Gaglio, D., Metallo, C. M., Gameiro, P. A., Hiller, K., Danna, L. S., Balestrieri, C., Alberghina, L., Stephanopoulos, G. and Chiaradonna, F. (2011) Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol. Syst. Biol. 7, 523.
|
29 |
Gao, P., Tchernyshyov, I., Chang, T. C., Lee, Y. S., Kita, K., Ochi, T., Zeller, K. I., De Marzo, A. M., Van Eyk, J. E., Mendell, J. T. and Dang, C. V. (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762-765.
|
30 |
Giacobbe, A., Bongiorno-Borbone, L., Bernassola, F., Terrinoni, A., Markert, E. K., Levine, A. J., Feng, Z., Agostini, M., Zolla, L., Agro, A. F., Notterman, D. A., Melino, G. and Peschiaroli, A. (2013) p63 regulates glutaminase 2 expression. Cell Cycle 12, 1395-1405.
DOI
|
31 |
Gorrini, C., Harris, I. S. and Mak, T. W. (2013) Modulation of oxidative stress as an anticancer strategy. Nat. Rev. Drug Discov. 12, 931-947.
DOI
|
32 |
Gross, M. I., Demo, S. D., Dennison, J. B., Chen, L., Chernov-Rogan, T., Goyal, B., Janes, J. R., Laidig, G. J., Lewis, E. R., Li, J., Mackinnon, A. L., Parlati, F., Rodriguez, M. L., Shwonek, P. J., Sjogren, E. B., Stanton, T. F., Wang, T., Yang, J., Zhao, F. and Bennett, M. K. (2014) Antitumor activity of the glutaminase inhibitor CB-839 in triple-negative breast cancer. Mol. Cancer Ther. 13, 890-901.
DOI
|
33 |
White, E. (2012) Deconvoluting the context-dependent role for autophagy in cancer. Nat. Rev. Cancer 12, 401-410.
DOI
|
34 |
van Geldermalsen, M., Wang, Q., Nagarajah, R., Marshall, A. D., Thoeng, A., Gao, D., Ritchie, W., Feng, Y., Bailey, C. G., Deng, N., Harvey, K., Beith, J. M., Selinger, C. I., O'Toole, S. A., Rasko, J. E. and Holst, J. (2016) ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer. Oncogene 35, 3201-3208.
DOI
|
35 |
Vander Heiden, M. G., Cantley, L. C. and Thompson, C. B. (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033.
DOI
|
36 |
Velletri, T., Romeo, F., Tucci, P., Peschiaroli, A., Annicchiarico-Petruzzelli, M., Niklison-Chirou, M. V., Amelio, I., Knight, R. A., Mak, T. W., Melino, G. and Agostini, M. (2013) GLS2 is transcriptionally regulated by p73 and contributes to neuronal differentiation. Cell Cycle 12, 3564-3573.
DOI
|
37 |
Windmueller, H. G. and Spaeth, A. E. (1974) Uptake and metabolism of plasma glutamine by the small intestine. J. Biol. Chem. 249, 5070-5079.
|
38 |
Wolfson, R. L., Chantranupong, L., Saxton, R. A., Shen, K., Scaria, S. M., Cantor, J. R. and Sabatini, D. M. (2016) Sestrin2 is a leucine sensor for the mTORC1 pathway. Science 351, 43-48.
DOI
|
39 |
Erickson, J. W. and Cerione, R. A. (2010) Glutaminase: a hot spot for regulation of cancer cell metabolism? Oncotarget 1, 734-740.
|
40 |
Wise, D. R., DeBerardinis, R. J., Mancuso, A., Sayed, N., Zhang, X. Y., Pfeiffer, H. K., Nissim, I., Daikhin, E., Yudkoff, M., McMahon, S. B. and Thompson, C. B. (2008) Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. U.S.A. 105, 18782-18787.
DOI
|
41 |
Hensley, C. T., Wasti, A. T. and DeBerardinis, R. J. (2013) Glutamine and cancer: cell biology, physiology, and clinical opportunities. J. Clin. Invest. 123, 3678-3684.
DOI
|
42 |
Xiang, L., Xie, G., Liu, C., Zhou, J., Chen, J., Yu, S., Li, J., Pang, X., Shi, H. and Liang, H. (2013) Knock-down of glutaminase 2 expression decreases glutathione, NADH, and sensitizes cervical cancer to ionizing radiation. Biochim. Biophys. Acta 1833, 2996-3005.
DOI
|
43 |
Xiang, Y., Stine, Z. E., Xia, J., Lu, Y., O'Connor, R. S., Altman, B. J., Hsieh, A. L., Gouw, A. M., Thomas, A. G., Gao, P., Sun, L., Song, L., Yan, B., Slusher, B. S., Zhuo, J., Ooi, L. L., Lee, C. G., Mancuso, A., McCallion, A. S., Le, A., Milone, M. C., Rayport, S., Felsher, D. W. and Dang, C. V. (2015) Targeted inhibition of tumor-specific glutaminase diminishes cell-autonomous tumorigenesis. J. Clin. Invest. 125, 2293-2306.
DOI
|
44 |
Yang, L., Achreja, A., Yeung, T. L., Mangala, L. S., Jiang, D., Han, C., Baddour, J., Marini, J. C., Ni, J., Nakahara, R., Wahlig, S., Chiba, L., Kim, S. H., Morse, J., Pradeep, S., Nagaraja, A. S., Haemmerle, M., Kyunghee, N., Derichsweiler, M., Plackemeier, T., Mercado- Uribe, I., Lopez-Berestein, G., Moss, T., Ram, P. T., Liu, J., Lu, X., Mok, S. C., Sood, A. K. and Nagrath, D. (2016) Targeting stromal glutamine synthetase in tumors disrupts tumor microenvironmentregulated cancer cell growth. Cell Metab. 24, 685-700.
DOI
|
45 |
Hassanein, M., Qian, J., Hoeksema, M. D., Wang, J., Jacobovitz, M., Ji, X., Harris, F. T., Harris, B. K., Boyd, K. L., Chen, H., Eisenberg, R. and Massion, P. P. (2015) Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer. Int. J. Cancer 137, 1587-1597.
DOI
|
46 |
He, C. and Klionsky, D. J. (2009) Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43, 67-93.
DOI
|
47 |
Hernandez-Davies, J. E., Tran, T. Q., Reid, M. A., Rosales, K. R., Lowman, X. H., Pan, M., Moriceau, G., Yang, Y., Wu, J., Lo, R. S. and Kong, M. (2015) Vemurafenib resistance reprograms melanoma cells towards glutamine dependence. J. Transl. Med. 13, 210.
DOI
|
48 |
Hosokawa, N., Sasaki, T., Iemura, S., Natsume, T., Hara, T. and Mizushima, N. (2009) Atg101, a novel mammalian autophagy protein interacting with Atg13. Autophagy 5, 973-979.
DOI
|
49 |
Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A. and Feng, Z. (2010) Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function. Proc. Natl. Acad. Sci. U.S.A. 107, 7455-7460.
DOI
|
50 |
Yang, L., Moss, T., Mangala, L. S., Marini, J., Zhao, H., Wahlig, S., Armaiz-Pena, G., Jiang, D., Achreja, A., Win, J., Roopaimoole, R., Rodriguez-Aguayo, C., Mercado-Uribe, I., Lopez-Berestein, G., Liu, J., Tsukamoto, T., Sood, A. K., Ram, P. T. and Nagrath, D. (2014) Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer. Mol. Syst. Biol. 10, 728.
DOI
|
51 |
Yang, L., Venneti, S. and Nagrath, D. (2017) Glutaminolysis: A Hallmark of Cancer Metabolism. Annu. Rev. Biomed. Eng. 19, 163-194.
DOI
|
52 |
Yoshida, G. J. (2015) Metabolic reprogramming: the emerging concept and associated therapeutic strategies. J. Exp. Clin. Cancer Res. 34, 111.
DOI
|
53 |
Zhang, C., Liu, J., Zhao, Y., Yue, X., Zhu, Y., Wang, X., Wu, H., Blanco, F., Li, S., Bhanot, G., Haffty, B. G., Hu, W. and Feng, Z. (2016) Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis. Elife 5, e10727.
|
54 |
Jacque, N., Ronchetti, A. M., Larrue, C., Meunier, G., Birsen, R., Willems, L., Saland, E., Decroocq, J., Maciel, T. T., Lambert, M., Poulain, L., Hospital, M. A., Sujobert, P., Joseph, L., Chapuis, N., Lacombe, C., Moura, I. C., Demo, S., Sarry, J. E., Recher, C., Mayeux, P., Tamburini, J. and Bouscary, D. (2015) Targeting glutaminolysis has antileukemic activity in acute myeloid leukemia and synergizes with BCL-2 inhibition. Blood 126, 1346-1356.
DOI
|
55 |
Hanahan, D. and Weinberg, R. A. (2011) Hallmarks of cancer: the next generation. Cell 144, 646-674.
DOI
|
56 |
Yu, D., Shi, X., Meng, G., Chen, J., Yan, C., Jiang, Y., Wei, J. and Ding, Y. (2015) Kidney-type glutaminase (GLS1) is a biomarker for pathologic diagnosis and prognosis of hepatocellular carcinoma. Oncotarget 6, 7619-7631.
|
57 |
Yuneva, M., Zamboni, N., Oefner, P., Sachidanandam, R. and Lazebnik, Y. (2007) Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J. Cell Biol. 178, 93-105.
|
58 |
Yuneva, M. O., Fan, T. W., Allen, T. D., Higashi, R. M., Ferraris, D. V., Tsukamoto, T., Mates, J. M., Alonso, F. J., Wang, C., Seo, Y., Chen, X. and Bishop, J. M. (2012) The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. Cell Metab. 15, 157-170.
DOI
|
59 |
Zhang, J., Wang, C., Chen, M., Cao, J., Zhong, Y., Chen, L., Shen, H. M. and Xia, D. (2013) Epigenetic silencing of glutaminase 2 in human liver and colon cancers. BMC Cancer 13, 601.
DOI
|
60 |
Zoncu, R., Efeyan, A. and Sabatini, D. M. (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat. Rev. Mol. Cell Biol. 12, 21-35.
DOI
|
61 |
Kim, M. J., Choi, Y. K., Park, S. Y., Jang, S. Y., Lee, J. Y., Ham, H. J., Kim, B. G., Jeon, H. J., Kim, J. H., Kim, J. G., Lee, I. K. and Park, K. G. (2017) reprograms glutamine metabolism in sorafenibresistant HCC. Mol. Cancer Res. 15, 1230-1242.
|
62 |
Jiang, L., Shestov, A. A., Swain, P., Yang, C., Parker, S. J., Wang, Q. A., Terada, L. S., Adams, N. D., McCabe, M. T., Pietrak, B., Schmidt, S., Metallo, C. M., Dranka, B. P., Schwartz, B. and DeBerardinis, R. J. (2016) Reductive carboxylation supports redox homeostasis during anchorage-independent growth. Nature 532, 255-258.
DOI
|
63 |
Jung, C. H., Jun, C. B., Ro, S. H., Kim, Y. M., Otto, N. M., Cao, J., Kundu, M. and Kim, D. H. (2009) ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 20, 1992-2003.
DOI
|
64 |
Katt, W. P., Antonyak, M. A. and Cerione, R. A. (2015) Simultaneously targeting tissue transglutaminase and kidney type glutaminase sensitizes cancer cells to acid toxicity and offers new opportunities for therapeutic intervention. Mol. Pharm. 12, 46-55.
DOI
|
65 |
Bhaskar, P. T. and Hay, N. (2007) The two TORCs and Akt. Dev. Cell 12, 487-502.
DOI
|
66 |
Alberghina, L. and Gaglio, D. (2014) Redox control of glutamine utilization in cancer. Cell Death Dis. 5, e1561.
DOI
|
67 |
Altman, B. J., Stine, Z. E. and Dang, C. V. (2016) From Krebs to clinic: glutamine metabolism to cancer therapy. Nat. Rev. Cancer 16, 773.
|
68 |
Baenke, F., Chaneton, B., Smith, M., Van Den Broek, N., Hogan, K., Tang, H., Viros, A., Martin, M., Galbraith, L., Girotti, M. R., Dhomen, N., Gottlieb, E. and Marais, R. (2016) Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells. Mol. Oncol. 10, 73-84.
DOI
|
69 |
Korangath, P., Teo, W. W., Sadik, H., Han, L., Mori, N., Huijts, C. M., Wildes, F., Bharti, S., Zhang, Z., Santa-Maria, C. A., Tsai, H., Dang, C. V., Stearns, V., Bhujwalla, Z. M. and Sukumar, S. (2015) Targeting glutamine metabolism in breast cancer with aminooxyacetate. Clin. Cancer Res. 21, 3263-3273.
DOI
|
70 |
Kim, S. Y. (2015) Cancer metabolism: targeting cancer universality. Arch. Pharm. Res. 38, 299-301.
|
71 |
Kuo, T. C., Chen, C. K., Hua, K. T., Yu, P., Lee, W. J., Chen, M. W., Jeng, Y. M., Chien, M. H., Kuo, K. T., Hsiao, M. and Kuo, M. L. (2016) Glutaminase 2 stabilizes Dicer to repress Snail and metastasis in hepatocellular carcinoma cells. Cancer Lett. 383, 282-294.
DOI
|
72 |
Bryant, K. L., Mancias, J. D., Kimmelman, A. C. and Der, C. J. (2014) KRAS: feeding pancreatic cancer proliferation. Trends Biochem. Sci. 39, 91-100.
DOI
|
73 |
Le, A., Lane, A. N., Hamaker, M., Bose, S., Gouw, A., Barbi, J., Tsukamoto, T., Rojas, C. J., Slusher, B. S., Zhang, H., Zimmerman, L. J., Liebler, D. C., Slebos, R. J., Lorkiewicz, P. K., Higashi, R. M., Fan, T. W. and Dang, C. V. (2012) Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab. 15, 110-121.
DOI
|
74 |
Lee, J. I., Kang, J. and Stipanuk, M. H. (2006) Differential regulation of glutamate-cysteine ligase subunit expression and increased holoenzyme formation in response to cysteine deprivation. Biochem. J. 393, 181-190.
DOI
|
75 |
Lee, J. S., Kang, J. H., Lee, S. H., Hong, D., Son, J., Hong, K. M., Song, J. and Kim, S. Y. (2016) Dual targeting of glutaminase 1 and thymidylate synthase elicits death synergistically in NSCLC. Cell Death Dis. 7, e2511.
|
76 |
Bhutia, Y. D., Babu, E., Ramachandran, S. and Ganapathy, V. (2015) Amino Acid transporters in cancer and their relevance to "glutamine addiction": novel targets for the design of a new class of anticancer drugs. Cancer Res. 75, 1782-1788.
DOI
|
77 |
Boroughs, L. K. and DeBerardinis, R. J. (2015) Metabolic pathways promoting cancer cell survival and growth. Nat. Cell Biol. 17, 351-359.
DOI
|
78 |
Bunpo, P., Murray, B., Cundiff, J., Brizius, E., Aldrich, C. J. and Anthony, T. G. (2008) Alanyl-glutamine consumption modifies the suppressive effect of L-asparaginase on lymphocyte populations in mice. J. Nutr. 138, 338-343.
|
79 |
Byun, J. K., Choi, Y. K., Kim, J. H., Jeong, J. Y., Jeon, H. J., Kim, M. K., Hwang, I., Lee, S. Y., Lee, Y. M., Lee, I. K. and Park, K. G. (2017) A positive feedback loop between sestrin2 and mTORC2 is required for the survival of glutamine-depleted lung cancer cells. Cell Rep. 20, 586-599.
DOI
|
80 |
Chen, L. and Cui, H. (2015) Targeting glutamine induces apoptosis: a cancer therapy approach. Int. J. Mol. Sci. 16, 22830-22855.
DOI
|
81 |
Cheong, H., Lindsten, T. and Thompson, C. B. (2012) Autophagy and ammonia. Autophagy 8, 122-123.
DOI
|
82 |
Curthoys, N. P. and Watford, M. (1995) Regulation of glutaminase activity and glutamine metabolism. Annu. Rev. Nutr. 15, 133-159.
DOI
|
83 |
Lushchak, V. I. (2012) Glutathione homeostasis and functions: potential targets for medical interventions. J. Amino Acids 2012, 736837.
|
84 |
Li, D., Fu, Z., Chen, R., Zhao, X., Zhou, Y., Zeng, B., Yu, M., Zhou, Q., Lin, Q., Gao, W., Ye, H., Zhou, J., Li, Z., Liu, Y. and Chen, R. (2015) Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy. Oncotarget 6, 31151-31163.
|
85 |
Locasale, J. W. (2013) Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat. Rev. Cancer 13, 572-583.
DOI
|
86 |
Lubos, E., Loscalzo, J. and Handy, D. E. (2011) Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid. Redox Signal. 15, 1957-1997.
|